Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 24.01B | 23.88B | 23.89B | 26.64B | 29.45B | 22.28B |
Gross Profit | 14.77B | 14.21B | 14.03B | 16.19B | 17.95B | 12.47B |
EBITDA | 6.75B | 7.28B | 7.50B | 9.48B | 10.01B | 6.54B |
Net Income | 3.41B | 3.90B | 4.76B | 7.21B | 6.43B | 3.65B |
Balance Sheet | ||||||
Total Assets | 81.62B | 77.54B | 84.49B | 84.35B | 83.18B | 76.16B |
Cash, Cash Equivalents and Short-Term Investments | 2.96B | 2.08B | 5.86B | 6.00B | 2.59B | 6.04B |
Total Debt | 18.55B | 17.15B | 19.54B | 20.62B | 23.27B | 22.18B |
Total Liabilities | 29.28B | 27.99B | 31.00B | 34.26B | 38.01B | 36.38B |
Stockholders Equity | 52.33B | 49.54B | 53.49B | 50.08B | 45.17B | 39.77B |
Cash Flow | ||||||
Free Cash Flow | 4.86B | 5.30B | 5.78B | 7.37B | 7.06B | 5.42B |
Operating Cash Flow | 6.17B | 6.69B | 7.16B | 8.52B | 8.36B | 6.21B |
Investing Cash Flow | -1.80B | -1.98B | -7.08B | -2.23B | -12.99B | -21.24B |
Financing Cash Flow | -4.04B | -8.38B | -273.00M | -2.57B | 1.29B | 1.01B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
79 Outperform | $32.64B | 28.34 | 18.88% | 0.85% | 0.56% | -4.08% | |
77 Outperform | $51.36B | 53.43 | 64.87% | ― | 5.56% | 4.66% | |
77 Outperform | $176.13B | 27.00 | 13.44% | 0.35% | 2.05% | 7.03% | |
71 Outperform | $16.74B | 25.35 | 37.03% | ― | 2.57% | 8.31% | |
66 Neutral | $142.52B | 42.28 | 6.68% | 0.59% | -3.24% | -16.60% | |
63 Neutral | $25.62B | 30.95 | -680.23% | ― | 3.11% | 8.50% | |
50 Neutral | AU$2.60B | 3.65 | -58.14% | 2.69% | 36.37% | 13.78% |
On July 28, 2025, Danaher Corporation announced that Brian W. Ellis, the Senior Vice President and General Counsel, will step down from his role as General Counsel on August 25, 2025. He will remain as Senior Vice President until his retirement on February 28, 2026, marking a significant transition in the company’s executive leadership.
The most recent analyst rating on (DHR) stock is a Buy with a $268.00 price target. To see the full list of analyst forecasts on Danaher stock, see the DHR Stock Forecast page.
On July 21, 2025, Danaher Corporation announced that Matthew M. McGrew, the current Chief Financial Officer, will step down from his role on February 28, 2026, and will be succeeded by Matthew E. Gugino. Gugino, who has been with Danaher since 2013, currently serves as Vice President-Corporate FP&A and Group CFO for the Life Sciences Innovations businesses. The transition is part of a strategic move to ensure continuity in leadership as McGrew transitions towards retirement. The announcement also detailed changes in compensation for both executives, with Gugino receiving significant increases in salary and equity awards as he assumes the CFO role. This transition is expected to support Danaher’s continued growth and strengthen its position as a leader in science and technology.
The most recent analyst rating on (DHR) stock is a Buy with a $315.00 price target. To see the full list of analyst forecasts on Danaher stock, see the DHR Stock Forecast page.
On May 6, 2025, Danaher Corporation held its annual shareholder meeting where key proposals were voted on, including the election of thirteen directors and the ratification of Ernst & Young LLP as the independent accounting firm for 2025. The meeting also saw the approval of the executive compensation package, reflecting shareholder support for the company’s leadership and strategic direction.